Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
-
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference
-
Aptose Biosciences Establishes New At-The-Market Facility
-
Aptose Announces Closing of Public Offering of Common Shares
-
Aptose Biosciences (APTO) Prices 16.125M Share Common Offering at $4/Sh
-
Aptose Announces Pricing of Public Offering of Common Shares
-
Aptose Biosciences (APTO) Commences Public Offering of Common Shares
-
Aptose Announces Proposed Public Offering of Common Shares
-
Aptose Reports Results for the Second Quarter Ended June 30, 2019
-
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference
-
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
-
Aptose Announces Closing of Public Offering of Common Shares
-
Aptose Biosciences (APTO) Prices 10M Share Common Offering at $1.85/Sh
-
Aptose Announces Pricing of Public Offering of Common Shares
-
Aptose Biosciences (APTO) Commences Public Offering of Common Shares
-
Aptose Announces Proposed Public Offering of Common Shares
-
Aptose Biosciences Establishes New At-The-Market Facility
-
Aptose Biosciences to Present at Canaccord Genuity 38th Annual Growth Conference
-
Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference
-
Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day
-
Aptose Biosciences to Present at Canaccord Genuity 36th Annual Growth Conference
-
Aptose Biosciences to Present at Canaccord Genuity 35th Annual Growth Conference
-
Canaccord Genuity Starts Aptose Biosciences (APTO) at Buy

